BlackRock Investment Management’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$1.35M Buy
95,013
+440
+0.5% +$6.82K ﹤0.01% 2497
2016
Q3
$1.66M Sell
94,573
-182
-0.2% -$3.02K ﹤0.01% 2310
2016
Q2
$1.62M Buy
94,755
+11,095
+13% +$198K ﹤0.01% 2277
2016
Q1
$1.65M Buy
83,660
+2,281
+3% +$36.6K ﹤0.01% 2130
2015
Q4
$1.55M Sell
81,379
-209
-0.3% -$4.26K ﹤0.01% 2261
2015
Q3
$1.56M Sell
81,588
-458
-0.6% -$15.6K ﹤0.01% 2258
2015
Q2
$3.81M Buy
82,046
+15,222
+23% +$660K ﹤0.01% 1716
2015
Q1
$2.92M Buy
66,824
+6,834
+11% +$318K ﹤0.01% 1768
2014
Q4
$2.08M Sell
59,990
-474
-0.8% -$19.2K ﹤0.01% 2006
2014
Q3
$2.53M Buy
60,464
+347
+0.6% +$15.5K ﹤0.01% 1825
2014
Q2
$3.52M Sell
60,117
-1,777
-3% -$112K ﹤0.01% 1653
2014
Q1
$3.9M Buy
61,894
+332
+0.5% +$22K 0.01% 1557
2013
Q4
$3.6M Sell
61,562
-1,554
-2% -$81.2K 0.01% 1585
2013
Q3
$3.33M Buy
63,116
+3,277
+5% +$220K 0.01% 1578
2013
Q2
$4.61M Buy
+59,839
New +$4.88M 0.01% 1273

Other funds holding ARNA

BlackRock Investment Management's ARNA Position: Q4 2016 in Review

BlackRock Investment Management increased its Arena Pharmaceuticals Inc (ARNA) stake by 0.47% in Q4 2016, buying an estimated $6.82K and bringing the position to 95,013 shares worth $1.35M. The position accounts for ﹤0.01% of the portfolio, ranked #2497.

BlackRock Investment Management first reported a position in ARNA in Q2 2013 and has held it in 15 quarters since. The position peaked at $4.61M in Q2 2013. 128 funds tracked by Wall St. Rank hold ARNA as of Q4 2016.

  • BlackRock Investment Management held 95,013 shares of Arena Pharmaceuticals Inc worth $1.35M as of Q4 2016.
  • BlackRock Investment Management bought 440 Arena Pharmaceuticals Inc shares in Q4 2016, an estimated $6.82K.
  • Arena Pharmaceuticals Inc made up ﹤0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #2497 holding.
  • BlackRock Investment Management first reported a position in Arena Pharmaceuticals Inc in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Investment Management's Arena Pharmaceuticals Inc position peaked at $4.61M in Q2 2013.
  • 128 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.